Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 84
Oncology Drugs 79
Optical Disorders Drugs 78
Optical 75
Immune Disorders Drugs 67
Cardiovascular Drugs 46
Biopharmaceuticals 40
Dermatological Drugs 38
Musculoskeletal Disorders Drugs 38
Genomics 30
Biotechnology 28
Clinical Trials 28
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 22
Skin Cancer Drugs 21
Infectious Diseases Drugs 19
Allergy and Immunology 17
Central Nervous System Drugs 17
Respiratory Drugs 17
Gastrointestinal Drugs 14
Allergy Drugs 14
Infusions and Injectables 13
Drugs by Therapeutic Area 11
Lung Cancer Drugs 11
Hematological Drugs 11
Leukemia Drugs 9
Dermatology 8
Oncology 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Diagnostics 7
Needles and Syringes 7
Biosimilars and Biosuperiors 6
Therapeutic Area 5
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Enzymes 5
Company Reports 4
Ovarian Cancer Drugs 4
Cardiovascular Devices 4
Transdermal and Transmucosal Drug Delivery 4
Vaccines 4
Liver and Kidney Disorders Drugs 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Pulmonary Medicine 3
Colon Cancer Drugs 3
Proteomics 3
Drug Delivery 3
Laboratory Equipment 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Diabetes Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Pediatrics 2
Neurology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Diabetes Devices 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Cardiology 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

676 Results (Page 22 of 34)
- Relevance
  Sort by

Antiglaucoma Drugs Global Market Report 2024

 Report
November 2023
175 Pages
Global

From

€4896EUR$5,000USD£4,072GBP

Atherosclerosis Therapeutics Market 2024-2028

 Report
June 2024
145 Pages
Global

From

€2448EUR$2,500USD£2,036GBP

Cell and Gene Therapy Bioassay Services Market by Type of Therapy, Therapeutic Area, Scale of Operation and Geography: Industry Trends and Global Forecasts, 2021-2030

 Report
January 2022
310 Pages
Global

From

€4699EUR$4,799USD£3,908GBP

AAV Vector Market: Focus on Drugs, Manufacturers and Technologies by Type of Therapy, Type of Gene Delivery Method Used, Target Therapeutic Area, Application Area, Scale of Operation and Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
August 2022
250 Pages
Global

From

€4699EUR$4,799USD£3,908GBP

Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, and Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
August 2022
689 Pages
Global

From

€4699EUR$4,799USD£3,908GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Anti-Inflammatory Drugs Market - Global Outlook & Forecast 2022-2027

 Report
April 2022
326 Pages
Global

From

€3672EUR$3,750USD£3,054GBP

PD-1 & PD-L1 Inhibitors Market by Product, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
194 Pages
Global

From

€3471EUR$3,545USD£2,887GBP

€3857EUR$3,939USD£3,208GBP

Eczema Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
180 Pages
Global

From

€4406EUR$4,500USD£3,665GBP

Pharmaceutical Drugs Industry: Global Competitive Landscape 2021

 Report
October 2022
307 Pages
Global

From

€5385EUR$5,500USD£4,479GBP

Investor Series: Opportunities in the Cell and Gene Therapy Market

 Report
April 2022
121 Pages
Global

From

€1859EUR$1,899USD£1,546GBP

Paroxysmal Nocturnal Hemoglobinuria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 Report
May 2024
129 Pages
Global

From

€6364EUR$6,499USD£5,292GBP

Pruritus Therapeutics Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4896EUR$5,000USD£4,072GBP

Diabetic Retinopathy Market by Type, Management - Global Forecast 2025-2030

 Report
October 2024
186 Pages
Global

From

€3471EUR$3,545USD£2,887GBP

€3857EUR$3,939USD£3,208GBP

Ophthalmology Drugs Global Market Opportunities and Strategies to 2031

 Report
January 2023
470 Pages
Global

From

€4896EUR$5,000USD£4,072GBP

Autoimmune Drugs Market 2024-2028

 Report
July 2024
185 Pages
Global

From

€2448EUR$2,500USD£2,036GBP

Lower Respiratory Tract Therapeutics Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4896EUR$5,000USD£4,072GBP

Global Genome Editing/Genome Engineering Market by Application, Technology, and End User, Regional Outlook - Forecast up to 2030

 Report
January 2024
130 Pages
Global

From

€3745EUR$3,825USD£3,115GBP

€4406EUR$4,500USD£3,665GBP

Severe Acute Respiratory-Syndrome Treatment Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4896EUR$5,000USD£4,072GBP

Paroxysmal Nocturnal Hemoglobinuria (PNH) Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4896EUR$5,000USD£4,072GBP

Nasal Polyps Treatment Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4896EUR$5,000USD£4,072GBP

676 Results (Page 22 of 34)
- 1
- 20
- 21
- 22
- 23
- 24

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.